These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway. Hong S, Yu S, Li J, Yin Y, Liu Y, Zhang Q, Guan H, Li Y, Xiao H. Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302 [Abstract] [Full Text] [Related]
7. The BRAFV600E oncogene induces transforming growth factor beta secretion leading to sodium iodide symporter repression and increased malignancy in thyroid cancer. Riesco-Eizaguirre G, Rodríguez I, De la Vieja A, Costamagna E, Carrasco N, Nistal M, Santisteban P. Cancer Res; 2009 Nov 01; 69(21):8317-25. PubMed ID: 19861538 [Abstract] [Full Text] [Related]
9. Cep63 knockout inhibits the malignant phenotypes of papillary thyroid cancer cell line TPC‑1. Liu C, Yu F, Ma R, Zhang L, Du G, Niu D, Yin D. Oncol Rep; 2021 Sep 01; 46(3):. PubMed ID: 34296302 [Abstract] [Full Text] [Related]
10. Upregulation of lncRNA-ATB by Transforming Growth Factor β1 (TGF-β1) Promotes Migration and Invasion of Papillary Thyroid Carcinoma Cells. Cui M, Chang Y, Du W, Liu S, Qi J, Luo R, Luo S. Med Sci Monit; 2018 Jul 25; 24():5152-5158. PubMed ID: 30042377 [Abstract] [Full Text] [Related]
11. Long noncoding RNA cancer susceptibility candidate 2 suppresses papillary thyroid carcinoma growth by inactivating the AKT/ERK1/2 signaling pathway. Huang F, Zhang Q, Chen W, Zhang H, Lu G, Chen J, Qiu C. J Cell Biochem; 2019 Jun 25; 120(6):10380-10390. PubMed ID: 30609134 [Abstract] [Full Text] [Related]
12. Epigenetically upregulated WIPF1 plays a major role in BRAF V600E-promoted papillary thyroid cancer aggressiveness. Zhang T, Shen X, Liu R, Zhu G, Bishop J, Xing M. Oncotarget; 2017 Jan 03; 8(1):900-914. PubMed ID: 27863429 [Abstract] [Full Text] [Related]
14. SLC34A2 simultaneously promotes papillary thyroid carcinoma growth and invasion through distinct mechanisms. He J, Zhou M, Li X, Gu S, Cao Y, Xing T, Chen W, Chu C, Gu F, Zhou J, Jin Y, Ma J, Ma D, Zou Q. Oncogene; 2020 Mar 03; 39(13):2658-2675. PubMed ID: 32005974 [Abstract] [Full Text] [Related]
18. USP33 is a Biomarker of Disease Recurrence in Papillary Thyroid Carcinoma. Jia M, Guo Y, Lu X. Cell Physiol Biochem; 2018 Mar 03; 45(5):2044-2053. PubMed ID: 29533940 [Abstract] [Full Text] [Related]
19. RASSF10 is Epigenetically Inactivated and Suppresses Cell Proliferation and Induces Cell Apoptosis by Activating the p53 Signalling Pathway in Papillary Thyroid Carcinoma Cancer. Fan C, Wang W, Jin J, Yu Z, Xin X. Cell Physiol Biochem; 2017 Mar 03; 41(3):1229-1239. PubMed ID: 28268222 [Abstract] [Full Text] [Related]